Matches in Nanopublications for { ?s ?p "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP593334.RA1mkrH3fnwgTe-tIlcM4YodO_ashQmb8SOijDcSG8UZw130_assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593334.RA1mkrH3fnwgTe-tIlcM4YodO_ashQmb8SOijDcSG8UZw130_provenance.
- assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP247011.RAc17-BeoOJMYeAyttUMUsVM0dysckWX0npMonuA1LDGw130_assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247011.RAc17-BeoOJMYeAyttUMUsVM0dysckWX0npMonuA1LDGw130_provenance.
- NP247012.RAr1STIgygq0HM2lzXtvhBZYJfY2cplUMxJDM7-UcmOu0130_assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247012.RAr1STIgygq0HM2lzXtvhBZYJfY2cplUMxJDM7-UcmOu0130_provenance.
- NP247016.RAhLFC0qj9XIZ-JoSjx-niyMJZuVSQ6uW5z6km67yp4LI130_assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247016.RAhLFC0qj9XIZ-JoSjx-niyMJZuVSQ6uW5z6km67yp4LI130_provenance.
- NP247017.RAgQOlSsNlrCmChw-4GeAL3jbdCxd26k-Fm4dJtD4xHEA130_assertion description "[The skeletal muscle activity of protein tyrosine phosphates 1B (PTP1B), a modulator of insulin and IGF-1 signaling, is reduced in obese nondiabetic subjects and in subjects with type 2 diabetes in comparison with leaner, nondiabetic controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247017.RAgQOlSsNlrCmChw-4GeAL3jbdCxd26k-Fm4dJtD4xHEA130_provenance.